Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist
-
MONACO, March 24, 2026 (GLOBE NEWSWIRE) -- From the preservation of ocean species to exploration on the Moon, from the study of underwater shipwrecks off the coast of Majorca to the oceans in space....
-
AIAA and Challenger Center announce 2026 Trailblazing STEM Educator Awards for three remarkable educators
-
Introducing Rozum: an AI reasoning engine built for high-stakes decisions - and the highest-scoring system on Humanity's Last Exam. Now in early access.